Description

This recording captures our AGBT 2024 workshop, highlighting the transformative impact of DNBSEQ™ technology The technology eliminates index hopping and clonal errors, enhancing accuracy, flexibility, and accessibility.

Silver Sponsor Workshop

Advancing Sequencing Capacities: Exploring DNBSEQ™ Technology and Complete WGS

Rade Drmanac, Chief Scientific Officer, Complete Genomics

Cost-effective Whole Genome Sequencing Method Identifies Clinically Relevant Germline Variants in Patients Recruited in A Breast Cancer Clinic

Ioannis Ragoussis, Head of Genome Sciences, McGill Genome Centre

Talks

Deep full-length single-cell RNA-seq enabled by DNBSEQ™ technology

Christoph Ziegenhain, Assistant Professor, Karolinska Institute/ Xpress Genomics

Revolutionizing Human Healthcare with Next-Generation Metagenome Sequencing

Maike Seifert, Head of unit, Karolinska Institute / AmbioGen

Impact of whole genome sequencing on precision medicine at scale

Andrea Riposati, CEO, Dante Genomics.

Democratizing Access to High-Throughput Proteomics

Cindy Lawley, Sr Director, Population Health, Olink Proteomics